Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-28

FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved a supplemental application for tacrolimus by Accord Healthcare Inc., expanding the availability of a generic tacrolimus product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)